Biotech Stock Corvus Pharmaceuticals Catapults To Nine-Year High On Eczema Results
Investor's Business Daily • • business
Key Points:
- Investor’s Business Daily (IBD) provides information for educational purposes and does not offer investment advice or solicitations to buy or sell securities.
- The data presented is sourced from what IBD believes to be reliable, but accuracy, timeliness, and suitability are not guaranteed.
- Past investment performance highlighted by IBD is not indicative of future results, and authors may hold positions in stocks they discuss.
- Real-time price data is provided by Nasdaq Last Sale, with ownership and estimate data from LSEG and FactSet, though not all markets are covered.
- All trademarks mentioned are owned by Investor’s Business Daily, LLC, and information is subject to change without notice.
